1.
Juda A, Rojek K, KamiƄska M, Strzoda A, Polak A. The use of the GLP-1 analog - dulaglutide in the treatment of morbid obesity - case report. J Educ Health Sport [Internet]. 2022 Nov. 28 [cited 2025 Jun. 29];13(1):146-52. Available from: https://apcz.umk.pl/JEHS/article/view/40820